Model DetailsLeukocyte - Lymphocyte - T-lymphocyte lymphoma - lymphoblastic
Model Name |
Leukocyte - Lymphocyte - T-lymphocyte lymphoma - lymphoblastic | Strain |
CD-1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
hematopoietic neoplasm • hematopoietic tumor • lymphoblastic lymphoma (T-cell origin) • lymphoblastic lymphoma |
Strain Synonyms |
outbred CD-1 • Swiss CD-1® • CD1 nontransgenic • Charles River CD-1 • Swiss CD-1 • Crl:CD-1®(ICR) • outbred CD1 • (Swiss) CD-1 • CD1 • Crl:CD-1(ICR)BR • ICR Crj:CD-1 • random-bred Crl:CD-1(ICR)BR • CD-1 outbred • Crl:CD-1 (ICR) BR • Crj:CD-1(ICR) • ICR(CD-1) • Crl: CD-1 (ICR) BR • ICR |
Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
---|---|---|---|---|---|
Leukocyte - Lymphocyte - T-lymphocyte | Female |
12.9% (4 of 31 mice) |
1 year |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
Leukocyte - Lymphocyte - T-lymphocyte | Female |
4.3% (1 of 23 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
Leukocyte - Lymphocyte - T-lymphocyte | Female |
9.3% (5 of 54 mice) |
1-2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
Leukocyte - Lymphocyte - T-lymphocyte | Male |
3.2% (1 of 31 mice) |
1 year |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
Leukocyte - Lymphocyte - T-lymphocyte | Male |
4.8% (1 of 21 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
Leukocyte - Lymphocyte - T-lymphocyte | Male |
3.8% (2 of 52 mice) |
1-2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |